Tolcapone 200 MG

DRUG3 trials

Sponsors

Sheppard Pratt Health System, University of Chicago, University of California, Berkeley

Conditions

Brain InjuriesBrain Injuries, TraumaticBrain Injury, ChronicDecision MakingDopamineExecutive FunctionObsessive-Compulsive Disorder

Early Phase 1

Dopaminergic Mechanisms Underlying Human Social Behavior

CompletedNCT04205994

University of California, BerkeleyDecision Making, Dopamine, Executive Function

Start: 2019-12-01End: 2023-12-31Updated: 2024-05-16

Phase 2

A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury

Sheppard Pratt Health SystemBrain Injuries, Brain Injuries, Traumatic, Brain Injury, Chronic

Start: 2017-07-20End: 2018-07-20Target: 16Updated: 2017-09-06

Tolcapone in Obsessive Compulsive Disorder

CompletedNCT03348930

University of ChicagoObsessive-Compulsive Disorder

Start: 2018-03-20End: 2020-12-14Updated: 2022-04-07